Startup | December 30, 2021
VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
The glucometer connects to one’s smartphone and provides actionable diagnostic information
The glucometer connects to one’s smartphone and provides actionable diagnostic information
2022 is going to be the year of opportunities and innovations from the medical industry in India
The proposed week-long event will comprise specific themes - International engagements, market access and incubation support, funding support to startups etc. and will cover the different areas of the innovation lifecycle
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
The interim data combines three mRNAs into one therapy injected directly into the tumour
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
The company is a medical dictation solution used by medical practitioners
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Second interchangeable biosimilar product approved by agency
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
